XILIO THERAPEUTICS
LIVE

Serial Number

99598865

Owner

XILIO DEVELOPMENT, INC.

Attorney

Valerie Brennan

First Use Date

Mar 2, 2021

Filing Date

Jan 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

XILIO THERAPEUTICS Trademark

Serial Number: 99598865 • Registration: 8377754

XILIO THERAPEUTICS is a trademark filed by XILIO DEVELOPMENT, INC. on January 16, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

XILIO DEVELOPMENT, INC. (7 trademarks)

Waltham, MA 02139

Entity Type: 03

Trademark Details

Filing Date

January 16, 2026

Registration Date

August 4, 2026

First Use Anywhere

March 2, 2021

First Use in Commerce

March 2, 2021

Published for Opposition

June 16, 2026

Goods & Services

Pharmaceutical products for the treatment of cancer, all of the foregoing excluding pharmaceutical products for sleep disorders, central nervous disorders other than cancers of the central nervous system, and neurological disorders other than cancers of the neurological system

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 4, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 4, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2026 NONP
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 18, 2026 GNEN
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
May 18, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
May 18, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 18, 2026 CNEA
ASSIGNED TO EXAMINER
May 14, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 16, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2026 NWOS
NEW APPLICATION ENTERED
Jan 16, 2026 NWAP